Eqis Capital Management Has Cut By $338,052 Its Cardinal Health (CAH) Position; Last Week RSA Insurance Group plc (LON:RSA) Coverage

Among 20 analysts covering RSA Insurance Group PLC (LON:RSA), 11 have Buy rating, 4 Sell and 5 Hold. Therefore 55% are positive. RSA Insurance Group PLC had 163 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, August 1 the stock rating was maintained by Deutsche Bank with “Hold”. The firm earned “Buy” rating on Thursday, November 23 by HSBC. The stock of RSA Insurance Group plc (LON:RSA) has “Neutral” rating given on Wednesday, July 29 by Nomura. JP Morgan maintained it with “Neutral” rating and GBX 448 target in Friday, November 6 report. The rating was maintained by Credit Suisse with “Outperform” on Friday, July 21. The company was upgraded on Tuesday, July 28 by Canaccord Genuity. The stock has “Hold” rating by Numis Securities on Thursday, February 25. On Thursday, November 5 the stock rating was maintained by Shore Capital with “Hold”. The rating was maintained by JP Morgan with “Overweight” on Friday, August 12. The firm earned “Sector Perform” rating on Tuesday, July 28 by RBC Capital Markets. See RSA Insurance Group plc (LON:RSA) latest ratings:

11/12/2017 Broker: Barclays Capital Rating: Overweight Old Target: GBX 663.00 New Target: GBX 678.00 Maintain
06/12/2017 Broker: Credit Suisse Rating: Outperform Old Target: GBX 720.00 New Target: GBX 700.00 Maintain
24/11/2017 Broker: RBC Capital Markets Rating: Outperform Maintain
23/11/2017 Broker: HSBC Rating: Buy Old Target: GBX 745.00 New Target: GBX 736.00 Maintain
16/11/2017 Broker: JP Morgan Rating: Overweight Maintain
06/11/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 725.00 New Target: GBX 725.00 Maintain
03/11/2017 Broker: Deutsche Bank Rating: Hold Old Target: GBX 620.00 New Target: GBX 620.00 Maintain
02/11/2017 Broker: Shore Capital Rating: Sell Maintain
24/10/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 700.00 New Target: GBX 725.00 Upgrade
26/09/2017 Broker: Citigroup Rating: Neutral Old Target: GBX 615.00 New Target: GBX 615.00 Maintain

Eqis Capital Management Inc decreased Cardinal Health Inc (CAH) stake by 45.89% reported in 2017Q3 SEC filing. Eqis Capital Management Inc sold 5,122 shares as Cardinal Health Inc (CAH)’s stock declined 8.93%. The Eqis Capital Management Inc holds 6,039 shares with $404,000 value, down from 11,161 last quarter. Cardinal Health Inc now has $19.66 billion valuation. The stock decreased 0.30% or $0.19 during the last trading session, reaching $62.49. About 2.28M shares traded. Cardinal Health, Inc. (NYSE:CAH) has declined 4.95% since December 26, 2016 and is downtrending. It has underperformed by 21.65% the S&P500.

The stock increased 0.41% or GBX 2.5 during the last trading session, reaching GBX 617.5. About 777,545 shares traded. RSA Insurance Group plc (LON:RSA) has 0.00% since December 26, 2016 and is . It has underperformed by 16.70% the S&P500.

RSA Insurance Group plc, together with its subsidiaries, provides personal and commercial general insurance products. The company has market cap of 6.22 billion GBP. It operates through Scandinavia, Canada, and UK & International divisions. It has a 49.8 P/E ratio. The firm offers a range of personal insurance products, including home, car, pet, and travel insurance products directly to its customers, as well as through brokers and agents.

Among 20 analysts covering Cardinal Health (NYSE:CAH), 5 have Buy rating, 1 Sell and 14 Hold. Therefore 25% are positive. Cardinal Health has $107 highest and $64 lowest target. $79.67’s average target is 27.49% above currents $62.49 stock price. Cardinal Health had 43 analyst reports since August 10, 2015 according to SRatingsIntel. As per Thursday, August 4, the company rating was maintained by Deutsche Bank. Jefferies maintained Cardinal Health, Inc. (NYSE:CAH) on Tuesday, October 3 with “Hold” rating. The firm earned “Outperform” rating on Tuesday, November 3 by RBC Capital Markets. The firm earned “Underweight” rating on Monday, November 20 by Morgan Stanley. The company was maintained on Tuesday, October 24 by Mizuho. The firm has “Neutral” rating by Goldman Sachs given on Friday, September 16. Credit Suisse maintained the stock with “Buy” rating in Thursday, August 3 report. The firm earned “Buy” rating on Monday, August 10 by Zacks. The firm earned “Outperform” rating on Tuesday, November 3 by FBR Capital. Needham initiated the stock with “Hold” rating in Tuesday, April 4 report.

Analysts await Cardinal Health, Inc. (NYSE:CAH) to report earnings on February, 6. They expect $1.14 EPS, down 14.93% or $0.20 from last year’s $1.34 per share. CAH’s profit will be $358.66 million for 13.70 P/E if the $1.14 EPS becomes a reality. After $1.09 actual EPS reported by Cardinal Health, Inc. for the previous quarter, Wall Street now forecasts 4.59% EPS growth.